Read + Share
Amedeo Smart
Independent Medical Education
Schmalz L, Bloomer C, Zhang W, Petty W, et al. Durable response to amivantamab in treatment refractory NSCLC harboring EGFR and complex MET mutations: A case report. Lung Cancer 2023;186:107400.PMID: 37856922
Email
LinkedIn
Facebook
Twitter
Privacy Policy